Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window It was feasible ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Long-term follow-up from the IABP-SHOCK II trial shows that the use of intra-aortic balloon pumps for ...

High-risk patients undergoing a coronary procedure such as placement of a stent who electively received an intra-aortic balloon pump (a device that can help improve blood flow) prior to the procedure ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

A percutaneous left ventricular assist device fails to offer improvement in 30-day outcomes compared with intra-aortic balloon pump (IABP) therapy in high-risk patients requiring hemodynamic support ...

Interv Cardiol. 2012;4(2):211-234. The future of IABC cannot, however, be taken in isolation. It must be analyzed in the context of other PCADs available for in-human use, namely the Impella Recover ...

CHICAGO, IL — Although marijuana use before an acute MI doesn't improve overall outcomes post-MI (the primary composite end point), it may be associated with improvement in several components, such as ...

WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic ...

CHICAGO, IL—Marijuana use is associated with lower short-term risks of death and shock among patients admitted for acute MI, although the need for mechanical ventilation is greater in pot users, an ...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, coronary and peripheral interventions, will ...